Streetbeat News

Stock Prices

SABS

SAB Biotherapeutics has received approval from Australian authorities to commence the Phase 1 clinical trial of SAB-142. This news has led to an increase in the company's share price.

Portfolio Pulse from Benzinga Newsdesk

October 19, 2023 | 3:58 pm

PGR

Progressive Corp's Q3 earnings significantly exceeded analyst expectations, reporting $2.09 versus the anticipated $1.72, marking a 21.51% surprise increase. This led to an 8% surge in the company's stock, surpassing the previous all-time high of $149 and the psychological resistance level of $150. Despite facing a lawsuit from America First Legal, the stock has remained steadfast in its upward trajectory, surging by 14% since October.

Portfolio Pulse from Zaheer Anwari

October 19, 2023 | 3:53 pm

PTSI

P.A.M. Transportation Services reported worse-than-expected Q3 financial results, leading to a drop in its share prices.

Portfolio Pulse from Benzinga Newsdesk

October 19, 2023 | 3:51 pm

GPC

Genuine Parts Co (NYSE:GPC) reported Q3 FY23 sales growth of 2.6% to $5.82 billion, missing the analyst consensus estimate of $5.92 billion. The company attributed the sales growth to an increase in comparable sales and benefit from acquisitions. Adjusted EPS of $2.49 beat the analyst consensus of $2.40. The company reaffirmed its FY23 revenue growth outlook of 4% - 6% and raised its FY23 adjusted EPS outlook from $9.15 - $9.30 to $9.20 - $9.30.

Portfolio Pulse from Shivani Kumaresan

October 19, 2023 | 3:46 pm

AAL

ERJ

American Airlines Group Inc has signed a firm order for four new E175s from Embraer S.A. The contract value is $230.6 million and will be included in Embraer's 2023 Q3 backlog. The aircraft will be operated by American's subsidiary, Envoy Air, with deliveries slated for the fourth quarter of 2024. This will increase Envoy's all E-Jet fleet to over 150 aircraft by the end of 2024.

Portfolio Pulse from Shivani Kumaresan

October 19, 2023 | 3:44 pm

HFWA

Heritage Financial's shares are trading higher following the company's Q3 earnings per share (EPS) results, which exceeded expectations.

Portfolio Pulse from Benzinga Newsdesk

October 19, 2023 | 3:43 pm

NUZE

NuZee Inc's shares have dropped by 46% to $2.77 following the company's pricing of a $1.275 million underwritten public offering of 425,000 shares at $3.00 per share. Maxim Group LLC is managing the offering, which is expected to close around October 20. NuZee's 52-week high is $21.35 and its low is $2.61.

Portfolio Pulse from Henry Khederian

October 19, 2023 | 3:35 pm

NXU

Nxu, Inc. (NASDAQ:NXU) shares dropped by 40.3% after the company announced a public offering of 86 million shares of Class A common stock at a price of $0.035 per share. The company aims to raise around $3 million from this offering, with the closing date set for October 23. Maxim Group LLC is the sole placement agent for this offering.

Portfolio Pulse from Henry Khederian

October 19, 2023 | 3:31 pm

WNS

WNS (Holdings) Ltd's shares have fallen by around 18% after the company reported its Q2 FY24 results and lowered its FY24 outlook. The company reported revenue of $325 million, slightly missing the consensus of $325.56 million. Adjusted EPS of $1.09, up 16% Y/Y, topped the consensus of $1.03. WNS ended Q2 FY24 with cash and investments of $248.1 million and debt of $164.1 million. The company lowered the outlook for adjusted revenue to $1.254 billion-$1.300 billion and adjusted EPS to $4.04-$4.24.

Portfolio Pulse from Lekha Gupta

October 19, 2023 | 3:31 pm

EW

Edwards Lifesciences (NYSE:EW) has outperformed the market over the past 15 years by 9.2% on an annualized basis, producing an average annual return of 20.42%. If an investor had bought $1000 of EW stock 15 years ago, it would be worth $16,181.57 today.

Portfolio Pulse from Benzinga Insights

October 19, 2023 | 3:30 pm